Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient mepolizumab (ATC code: R03DX09). - 9971

World Biggest Tenders Source

This tender with title Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient mepolizumab (ATC code: R03DX09). - 9971 has been published on Bidding Source portal dated 10 Jan 2025 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Tender Title :

Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient mepolizumab (ATC code: R03DX09). - 9971

Tender Type :

Invitation for Bids

Country :

Germany

Publish Date :

10 Jan 2025

Closing Date :

28 Dec 2026

Notice Language :

English

Tender Categories (CPVs) :

Pharmaceutical products

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 SGB V for the active ingredients mentioned with the possibility of conclusion within the framework of the so-called open house procedure. - 9802 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 of the Social Code Book V for the active substances mentioned with the possibility of conclusion within the framework of the so-called open house procedure. - 798173 Germany Pharmaceutical products – Open House discount contracts 2024-14 - 791163 Germany Conclusion of non-exclusive discount agreements according to Section 130 a Paragraph 8 SGB V in the period from 01.01.2025 - 30.06.2026 - 784579 Germany Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 or 130c Paragraph 1 SGB V for the period from 01.02.2025 to 31.01.2027 - 787542 Germany Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the Social Security Code (SGB V) by means of an OH model for the active ingredient Perindopril/Indapamide (ATC code according to WHO: C09BA04; official ATC code: C09BA54) - 783595 Germany Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the Social Security Code (SGB V) by means of an OH model for the active ingredient dexamethasone (ATC code according to WHO: S01BA01) - 782056 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 SGB V for the active ingredients mentioned with the possibility of conclusion within the framework of the so-called open house procedure. - 774130 Germany Conclusion of non-exclusive discount agreements pursuant to Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient nilotinib (L01EA03), without administration dispersed in apple sauce (pureed apple) within the framework of a so-called open-house model. - 774098 Germany Open house drug discount agreements Buserelin, ATC L02AE01 - 768779 Germany

Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient mepolizumab (ATC code: R03DX09). - 9971

General Information

Germany

Similar Tenders

Pharmaceutical products Tenders

Germany Tenders

Europe Tenders

Tenders

info@biddingsource.com